Notice Of Public Meeting: Laveen Village Planning Committee

Planning and Development

<div class="ExternalClass39DADBF01289433585102E54070125BA">Pursuant to A.R.S. Section 38-431.02, notice is hereby given to the members of the LAVEEN VILLAGE PLANNING COMMITTEE and to the general public, that the LAVEEN VILLAGE PLANNING COMMITTEE will hold a meeting open to the public on Monday, August 8, 2022, at 6:30 p.m. Per the most recent social distancing guidelines from the federal government, no residents will be allowed to attend the meeting in-person. To view the meeting notice and agenda please visit: <a href="/cityclerksite/PublicMeetings/220808003.pdf">https://www.phoenix.gov/cityclerksite/PublicMeetings/220808003.pdf</a><a href="/cityclerksite/PublicMeetings/211213001.pdf"></a><a href="/cityclerksite/PublicMeetings/210614001.pdf"></a><a href="/cityclerksite/PublicMeetings/210510002pdf.pdf"></a><a href="/cityclerksite/PublicMeetings/210315002.pdf"></a><a href="/cityclerksite/PublicMeetings/210111003.pdf"></a><a href="/cityclerksite/PublicMeetings/201012002.pdf">For additional Laveen Village information please visit: </a><a href="/villages/laveen">https://www.phoenix.gov/villages/laveen</a> ***End times are approximate.*** </div>

8/9/2022 1:30:00 AM

8/9/2022 4:30:00 AM

Les Scott 602-261-8980; TTY: Use 7-1-1

Julianna Pierre

602-534-5829

Electronically, via a video conferencing platform

Pursuant to A.R.S. Section 38-431.02, notice is hereby given to the members of the LAVEEN VILLAGE PLANNING COMMITTEE and to the general public, that the LAVEEN VILLAGE PLANNING COMMITTEE will hold a meeting open to the public on Monday, August 8, 2022, at 630 p.m. Per the most recent social distancing guidelines from the federal government, no residents will be allowed to attend the meeting in-person. T o view the meeting notice and agenda please visit https//www.phoenix.gov/cityclerksite/PublicMeetings/220808003.pdf For additional Laveen Village information please visit https//www.phoenix.gov/villages/laveen ***End times are approximate.***